Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Lomonitinib [inn]
2. U4dpu7w7qu
3. 1h-pyrazolo[4,3-c]quinoline, 3-(3,4-dimethoxyphenyl)-1-(1,2,3,4-tetrahydro-7-isoquinolinyl)-
4. 2923221-56-9
5. 3-(3,4-dimethoxyphenyl)-1-(1,2,3,4-tetrahydroisoquinolin-7-yl)-1h-pyrazolo[4,3-c]quinoline
6. 7-[3-(3,4-dimethoxyphenyl)-1h-pyrazolo[4,3-c]quinolin-1-yl]-1,2,3,4-tetrahydroisoquinoline
| Molecular Weight | 436.5 g/mol |
|---|---|
| Molecular Formula | C27H24N4O2 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 61.2 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 664 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
85
PharmaCompass offers a list of Lomonitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lomonitinib manufacturer or Lomonitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lomonitinib manufacturer or Lomonitinib supplier.
PharmaCompass also assists you with knowing the Lomonitinib API Price utilized in the formulation of products. Lomonitinib API Price is not always fixed or binding as the Lomonitinib Price is obtained through a variety of data sources. The Lomonitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lomonitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lomonitinib, including repackagers and relabelers. The FDA regulates Lomonitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lomonitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lomonitinib supplier is an individual or a company that provides Lomonitinib active pharmaceutical ingredient (API) or Lomonitinib finished formulations upon request. The Lomonitinib suppliers may include Lomonitinib API manufacturers, exporters, distributors and traders.
Lomonitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lomonitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lomonitinib GMP manufacturer or Lomonitinib GMP API supplier for your needs.
A Lomonitinib CoA (Certificate of Analysis) is a formal document that attests to Lomonitinib's compliance with Lomonitinib specifications and serves as a tool for batch-level quality control.
Lomonitinib CoA mostly includes findings from lab analyses of a specific batch. For each Lomonitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lomonitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Lomonitinib EP), Lomonitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lomonitinib USP).
